2025 OIG Year in Review: Part II—Providers
- February 13, 2026
- Lisa Re , Arnold & Porter Kaye Scholer LLP
- Lori Wright , Arnold & Porter Kaye Scholer LLP
- Lily Cao , Arnold & Porter Kaye Scholer LLP
Federal health care enforcement activity in 2025 underscored long-standing compliance risk areas across the provider landscape. As detailed in Part I: Life Sciences, the government continued to use the False Claims Act (FCA) and other program integrity tools to address improper federal health care spending and patient safety concerns. For health care providers, enforcement was driven less by novel legal theories and more by operational failures and weaknesses in internal monitoring and reporting systems.
ARTICLE TAGS
You must be logged in to access this content.